Celldex Therapeutics 10K 2015 Annual report | CLDX Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: abuse, abusive, ADCC, add, addressed, adhering, adolescent, advisory, analytical, atezolizumab, attack, attained, biosimilar, biosimilarity, blood, bound, BPCI, BPCIA, CBER, CDER, CE, cellsin, certification, chemistry, chronically, clarification, clearance, cloud, companion, complicating, constrain, contrast, convey, Cook, core, Corrupt, credible, curb, curve, customer, debilitating, defraud, deny, Department, deter, device, disgorgement, domestic, donor, drafted, DSMB, durable, effector, EGRFvIII, emphasizing, engraftment, entail, erected, eribulin, evolution, exerting, expert, explicit, fallopian, false, faster, FCPA, FDASIA, FDCA, feet, Ferentino, formulary, fraud, fraudulent, freely, function, fused, GCP, genetic, GLP, GmbH, graft, HIPAA, HITECH, horizon, Icahn, illegal, imiquimod, immunohistochemistry, Importantly, impossible, imprisonment, improper, improperly, incurrence, indirectly, ingredient, instance, institutionalize, interchangeable, introduced, intrusion, IRB, ITT, killer, knowingly, LabCorp, landscape, licensure, light, marked, marker, marking, Marrow, mesylate, mg, MilliporeSigma, misconduct, mononuclear, Mount, necessity, Needham, NJ, noncompliance, Novocure, ourin, outline, overcome, panel, paradigm, Park, passed, payor, penalty, people, percent, peripheral, peritoneal, permissive, pervasive, pharmacology, Pharmica, PHSA, physician, placement, plasmacytoid, PMA, Portability, pose, PPACA, preclude, PrECOG, premarket, pressure, privacy, prohibit, prohibiting, prohibition, Prolonged, proof, protracted, purity, Qiagen, QSR, qualification, radiotherapy, Recentin, recipient, reconsider, reconstitution, remission, remuneration, replacement, reputation, reputational, restitution, resubmission, resubmitted, revocation, Richard, Roswell, scalable, scheme, School, serve, shortage, shorten, shutdown, Similarly, Sinai, Sixty, slower, SOC, Society, software, soliciting, sooner, space, specialty, square, statute, strength, strictly, subpopulation, suspend, Sutent, Switzerland, synergy, tail, thereto, timepoint, today, topically, toxicity, transmission, transparency, tube, unacceptable, unannounced, unapproved, uniform, unmanaged, untitled, viability, waiting, waiver, willfully, withdrawn, world, Wright, Yervoy, Zug

Removed: Belinostat, circulating, consisting, differentiation, discontinuation, downstream, EMEA, fourth, frequently, funded, fusion, impressive, interval, mobilizer, multiforme, occupational, payer, permanent, power, progenitor, recovered, selectively, specificity, Spectrum, traded, undergo, undesirable, unique, upfront

Celldex Therapeutics (CLDX) 10-K2015 FY Annual report

Content analysis